A phase 1 trial of 4-(N-(S-penicillaminylacetyl)amino)-phenylarsonous acid (PENAO) in patients with advanced solid tumours
2021; Springer Science+Business Media; Volume: 87; Issue: 5 Linguagem: Inglês
10.1007/s00280-020-04225-7
ISSN1432-0843
AutoresSunit Sarkar, Ben Tran, Lisa G. Horvath, Michael Lam, Peter Savas, Peter Grimison, James R. Whittle, James Kuo, Nicole Signal, David J. Edmonds, Philip J. Hogg, Danny Rischin, Jayesh Desai, Anne Hamilton,
Tópico(s)Drug-Induced Ocular Toxicity
Referência(s)